Nirmatrelvir
ATC — · 9 markets · 15 records
AU 4 records · 2 strengths
Combination products containing this ingredient
- 150 mgtablet CombinationNirmatrelvir 150 mg + Ritonavir 100 mgPaxlovidPAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 2 records · 1 strengths
Combination products containing this ingredient
- 150 mgtablet CombinationNirmatrelvir 150 mg + Ritonavir 100 mgPaxlovidPAXLOVID (NIRMATRELVIR AND RITONAVIR) FILM-COATED TABLETS
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 1 records · 1 strengths
Only this ingredient
- 150 mgtabletManufacturer: Pfizer Ltd
CA 1 records · 1 strengths
Combination products containing this ingredient
- 150 mgtablet CombinationNirmatrelvir 150 mg + Ritonavir 100 mgPaxlovid
ES 1 records · 1 strengths
Combination products containing this ingredient
- 150 mgtablet CombinationNirmatrelvir 150 mg + Ritonavir 100 mgPaxlovid
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 150 mg tablet | Manufacturer: Pfizer Ltd | ||||||||
| 150 mg Combination Nirmatrelvir 150 mg + Ritonavir 100 mg tablet | Paxlovid | Paxlovid PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack | Paxlovid PAXLOVID (NIRMATRELVIR AND RITONAVIR) FILM-COATED TABLETS | Paxlovid | |||||
| Combination Nirmatrelvir + Ritonavir tablet | Paxlovid | Paxlovid 倍拉維150毫克/100毫克膜衣錠 | |||||||
| Combination Nirmatrelvir + Ritonavir unknown | Paxlovid | Paxlovid | Paxlovid |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in GB and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 GB 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Also called: P药 nickname
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.